| Literature DB >> 27247571 |
Seraina Obrist1, Slavko Rogan2, Roger Hilfiker1.
Abstract
Introduction. Falls are frequent in older adults and may have serious consequences but awareness of fall-risk is often low. A questionnaire might raise awareness of fall-risk; therefore we set out to construct and test such a questionnaire. Methods. Fall-risk factors and their odds ratios were extracted from meta-analyses and a questionnaire was devised to cover these risk factors. A formula to estimate the probability of future falls was set up using the extracted odds ratios. The understandability of the questionnaire and discrimination and calibration of the prediction formula were tested in a cohort study with a six-month follow-up. Community-dwelling persons over 60 years were recruited by an e-mail snowball-sampling method. Results and Discussion. We included 134 persons. Response rates for the monthly fall-related follow-up varied between the months and ranged from low 38% to high 90%. The proportion of present risk factors was low. Twenty-five participants reported falls. Discrimination was moderate (AUC: 0.67, 95% CI 0.54 to 0.81). The understandability, with the exception of five questions, was good. The wording of the questions needs to be improved and measures to increase the monthly response rates are needed before test-retest reliability and final predictive value can be assessed.Entities:
Year: 2016 PMID: 27247571 PMCID: PMC4877464 DOI: 10.1155/2016/1520932
Source DB: PubMed Journal: Curr Gerontol Geriatr Res ISSN: 1687-7063
Comparison of existing falls prediction tools for community-dwelling older adults.
| Name of tool | Publication | Fall outcome | Risk factors used in the final model | Follow-up period (months) | Area under the ROC-curve (if not stated otherwise) | Number of participants | Person with falls | Number of falls |
|---|---|---|---|---|---|---|---|---|
| AGS/BGS/AAOS algorithm | AGS/BGS/AAOS [ | Any fall |
| 12 | Likelihood ratio+ of 2.71, likelihood ratio− of 0.61 | 117 | 52 (44.4%) | |
|
| ||||||||
| Geriatric Postal Screening Survey (GPSS) | Alessi et al., 2003 [ | Any fall |
| 12 | Sensitivity 0.94, specificity 0.51 | 147 | ||
|
| ||||||||
| “Sturz-Risiko-check” (Falls-risk check) | Anders et al., 2006 [ | Any Fall |
| Cross-sectional study (test of reliability) | 117 | |||
| Bongue et al., 2011 [ | Any fall |
| 12 | 0.70 (0.67–0.73) | 1795 | 563 (32%) | ||
| Buatois et al., 2010 [ |
| 25 | 619 | |||||
|
| ||||||||
| FRAT-up | Cattelani et al., 2015 [ | Any fall |
| 36 | 0.64 (0.61–0.67) | 977 | 215 (22%) | |
| Covinsky et al., 2001 [ | Retrospective; fall or falls in the previous year |
| 60 | 0.71 | 95 (33%) | 197 | ||
|
| ||||||||
| EFST | Cwikel et al., 1998 [ |
| ||||||
|
| ||||||||
| DFRA | Demura et al., 2011 [ | Any fall |
| Retrospective falls history | 85.4% correct classified | 1122 | 177 (16%) | |
|
| ||||||||
| FRAS | El Miedany et al., 2011 [ | Any Fall |
| Case-control | 0.89 (0.86–0.92) | 985 | 559 (57%) | |
| Gadkaree et al., 2015 [ | Any fall | Age, gender, race, self-reported balance problem, history of fall | 12 | 0.70 (0.67–0.78) | 2539 | |||
| Hirase et al., 2014 [ |
| 3 | 0.73 (0.62–0.83) for the seven bold factors; 0.82 (0.70–0.95) for all 15 factors | 292 | 45 (15.6%) | |||
|
| ||||||||
| Modified Johns Hopkins fall-risk assessment tool mJH-FRAT | Hnizdo et al., 2013 [ | Any fall |
| During home health services (2 to 80 days) | 0.66 (0.55–0.78) | 107 | 33 (31%) | |
|
| ||||||||
| Physiological profile assessment | Lord et al., 2003 [ |
| ||||||
| Palumbo et al., 2015 [ |
| 36 | 0.64 (0.61–0.67) | 976 | 0.42 falls per person-year | |||
|
| ||||||||
| LASA fall-risk profile | Peeters et al., 2010 [ | At least 2 falls within 6 months |
| 12 | 0.65 (0.58–0.72) | 408 | 76 (recurrent fallers, 18.6%) | |
| Pluijm et al., 2006 [ | Prospective, recurrent falling at 3-year follow-up |
| 36 | 0.71 (0.67–0.74) | 1214 | 55.3% | 2570 | |
|
| ||||||||
| Fall-risk assessment and screening tool FRAST | Renfro and Fehrer, 2011 [ |
| ||||||
|
| ||||||||
| FRQ | Rubenstein et al., 2011 [ |
| ||||||
|
| ||||||||
| FROP-COM | Russell et al., 2008 [ | 13 risk factors covered with 26 questions. | 12 | 0.68 (0.63–0.74) | 344 | 164 (47.6%) | ||
|
| ||||||||
| FROP-COM screen | Russell et al., 2009 [ | Any fall |
| 12 | 0.73 (0.67–0.79) | 344 | 164 | |
| Stalenhoef et al., 2002 [ | Prospective, recurrent falls (≥2 falls) |
| 36 | 0.79 | 287 | |||
|
| ||||||||
| Thai-FRAT | Jittima Thamarpirat et al., 2008 [ | Any fall |
| 24 | Positive Likelihood-Ratio: 2.34 | 115 | ||
|
| ||||||||
| QuickScreen clinical fall-risk assessment | Tiedemann et al., 2010 [ | Multiple falls |
| 12 | 0.72 (0.66–0.79) | 362 | 179 (49%) | |
| Tromp et al., 2001 [ | Any fall |
| 12 | 0.65 | 1280 | 33% | ||
Empty cells indicate that we did not found any corresponding information in the publications.
Predictors. Predictors found in review of reviews and odds ratios from an existing self-administered fall-risk questionnaire (multivariable odds ratios) and our questionnaire (univariable odds ratio).
| Variable |
|
| Odds ratio | (95% CI) | Log of the odds ratio | Heterogeneity ( | Meta-analysis | OR El Miedany (FRAS) | OR Obrist |
|---|---|---|---|---|---|---|---|---|---|
| Age (per 5-year increase) | 8 | 1.11 | (1.05–1.17) | 0.10 |
| Deandrea et al., 2010 [ | 1.02 (1.01 to 1.04) | 1.69 (1.14 to 2.53) | |
|
| 12 | 5419 | 1.16 | (1.02–1.32) | 0.15 |
| Bloch et al., 2010 [ | ||
| Taking drugs (yes/no) | 5 | 508 | 4.24 | (3.06–5.88) | 1.45 | 16% | Bloch et al., 2013 [ | 2.68 (1.02 to 7.02) | |
|
| 7 | 7 611 | 2.03 | (1.52–2.72) | 0.71 | 0% | Bloch et al., 2013 [ | ||
|
| 32 | 43 552 | 1.74 | (1.56–1.95) | 0.55 | 0% | Bloch et al., 2013 [ | ||
| Polymedication | 29 | 25 098 | 1.71 | (1.50–1.96) | 0.54 | 38% | Bloch et al., 2013 [ | 3.04 (1.18 to 7.89) | |
|
| 26 | 54 919 | 1.61 | (1.35–1.93) | 0.48 | 0% | Bloch et al., 2013 [ | ||
| Antidepressants | 46 | 19 988 | 1.59 | (1.43–1.75) | 0.46 | 21% | Bloch et al., 2013 [ | ||
|
| 9 | 34 021 | 1.56 | (1.28–1.90) | 0.45 | 22% | Bloch et al., 2013 [ | ||
|
| 13 | 21 899 | 1.55 | (1.21–1.97) | 0.44 | 42% | Bloch et al., 2013 [ | ||
|
| 36 | 4 453 | 1.53 | (1.40–1.68) | 0.43 | 44% | Bloch et al., 2013 [ | ||
|
| 11 | 8 587 | 1.48 | (1.11–1.99) | 0.39 | 17% | Bloch et al., 2013 [ | ||
|
| 7 | 22 973 | 1.43 | (1.27–1.61) | 0.36 | 39% | Bloch et al., 2013 [ | ||
|
| 12 | 12 391 | 1.42 | (1.21–1.67) | 0.35 | 47% | Bloch et al., 2013 [ | ||
| Metabolic and endocrine medicines | 11 | 38 846 | 1.39 | (1.20–1.62) | 0.33 | 0% | Bloch et al., 2013 [ | ||
| Antipsychotics | 23 | 29 584 | 1.37 | (1.16–1.61) | 0.32 | 15% | Bloch et al., 2013 [ | ||
| Analgesics | 11 | 9 869 | 1.33 | (1.07–1.65) | 0.29 | 0% | Bloch et al., 2013 [ | ||
| Anti-inflammatory | 18 | 22 209 | 1.25 | (1.11–1.42) | 0.22 | 31% | Bloch et al., 2013 [ | ||
| ACE inhibitor | 6 | 66 696 | 1.21 | (1.15–1.28) | 0.19 | 39% | Bloch et al., 2013 [ | ||
| Vasodilators | 17 | 7 212 | 1.12 | (1.04–1.21) | 0.11 | 71% | Bloch et al., 2013 [ | ||
| Antihypertensives | 25 | 81 908 | 1.1 | (1.05–1.16) | 0.10 | 25% | Bloch et al., 2013 [ | ||
|
| 23 | 88 467 | 0.78 | (0.67–0.90) | −0.25 | 80% | Bloch et al., 2013 [ | ||
| Fall history | 39 | 25 808 | 3.86 | (3.42–4.37) | 1.35 | 58% | Bloch et al., 2013 [ | 1.5 (0.8 to 2.7) | 2.1 (0.78 to 5.69) |
| Fear of falling | 13 | 22 809 | 2.4 | (2.07–2.77) | 0.88 | 48% | Bloch et al., 2013 [ | 1.35 (0.37 to 4.99) | |
|
| 8 | 10 649 | 2.2 | (1.65–2.93) | 0.79 | 0% | Bloch et al., 2013 [ | ||
| Sensory disorder | 9 | 3 125 | 2.2 | (1.56–3.11) | 0.79 | 38% | Bloch et al., 2013 [ | 1.54 (0.48 to 5.03) | |
| Parkinson's disease | 29 | 39 477 | 2.19 | (1.68–2.84) | 0.78 | 50% | Bloch et al., 2013 [ | ||
| Neurological disease | 17 | 20 281 | 2.18 | (1.69–2.82) | 0.78 | 0% | Bloch et al., 2013 [ | 2.28 (0 to 11.45) | |
|
| 8 | 8 648 | 2.16 | (1.68–2.78) | 0.77 | 0% | Bloch et al., 2013 [ | ||
| Low body mass index | 12 | 15 396 | 2.05 | (1.70–2.48) | 0.72 | 0% | Bloch et al., 2013 [ | 4.5 (0.27 to 73.83) | |
|
| 35 | 59 363 | 1.96 | (1.80–2.14) | 0.67 | 88% | Bloch et al., 2013 [ | ||
| Fracture history | 11 | 1612 | 1.89 | (1.53–2.34) | 0.64 | 51% | Bloch et al., 2013 [ | Not estimable | |
| Urinary incontinence | 34 | 59 458 | 1.73 | (1.60–1.88) | 0.55 | 49% | Bloch et al., 2013 [ | 2.23 (0 to 17.89) | |
|
| 18 | 19 015 | 1.73 | (1.48–2.02) | 0.55 | 56% | Bloch et al., 2013 [ | ||
| Depression | 39 | 67 858 | 1.64 | (1.52–1.76) | 0.50 | 40% | Bloch et al., 2013 [ | 2.38 (0 to 19.27) | |
|
| 4 | 1 826 | 1.64 | (1.16–2.33) | 0.50 | 19% | Bloch et al., 2013 [ | ||
|
| 7 | 13 418 | 1.62 | (1.48–1.78) | 0.48 | 0% | Bloch et al., 2013 [ | ||
| Cardiac and vascular problems | 14 | 24 367 | 1.6 | (1.45–1.75) | 0.47 | 0% | Bloch et al., 2013 [ | 1.98 (0.82 to 4.76) | |
| Vision impairment | 39 | 38 671 | 1.49 | (1.39–1.59) | 0.40 | 47% | Bloch et al., 2013 [ | 2.8 (1.1 to 7.6) | 3.07 (0.58 to 16.43) |
|
| 5 | 502 | 1.47 | (1.15–1.88) | 0.39 | 0% | Bloch et al., 2013 [ | ||
|
| 49 | 54 336 | 1.44 | (1.34–1.56) | 0.37 | 20% | Bloch et al., 2013 [ | ||
|
| 9 | 3 402 | 1.42 | (1.14–1.75) | 0.35 | 0% | Bloch et al., 2013 [ | ||
| Hearing impairment | 17 | 21 878 | 1.37 | (1.27–1.48) | 0.32 | 11% | Bloch et al., 2013 [ | 1.3 (0.53 to 3.18) | |
|
| 16 | 31 443 | 1.29 | (1.18–1.40) | 0.26 | 24% | Bloch et al., 2013 [ | ||
|
| 9 | 13 786 | 1.28 | (1.15–1.43) | 0.25 | 34% | Bloch et al., 2013 [ | ||
| High blood pressure | 35 | 45 115 | 1.28 | (1.19–1.37) | 0.25 | 42% | Bloch et al., 2013 [ | 2.09 (0.81 to 5.43) | |
| Diabetes | 40 | 61 028 | 1.27 | (1.19–1.36) | 0.24 | 11% | Bloch et al., 2013 [ | 1.47 (0 to 10.9) | |
|
| 16 | 35 858 | 1.27 | (1.14–1.42) | 0.24 | 0.25 | Bloch et al., 2013 [ | ||
| Postural hypotension | 20 | 11 939 | 1.27 | (1.09–1.47) | 0.24 | 9% | Bloch et al., 2013 [ | 1.18 (0.44 to 3.22) | |
| Arthrosis/osteoarthritis | 37 | 5 284 | 1.24 | (1.20–1.28) | 0.22 | 88% | Bloch et al., 2013 [ | 0.76 (0.3 to 1.94) | |
|
| 22 | 1 754 | 1.22 | (1.12–1.32) | 0.20 | 46% | Bloch et al., 2013 [ | ||
|
| 10 | 26 642 | 1.22 | (1.09–1.35) | 0.20 | 44% | Bloch et al., 2013 [ | ||
| Abnormal walking test | 11 | 14 677 | 3.34 | (2.36–4.72) | 1.21 | 0% | Bloch et al., 2013 [ | ||
|
| 3 | 8 896 | 2.82 | (2.30–3.46) | 1.04 | 0% | Bloch et al., 2013 [ | ||
| Muscular weakness | 11 | 12 705 | 2.66 | (2.12–3.33) | 0.98 | 66% | Bloch et al., 2013 [ | 2.1 (1.1 to 4.4) | 4.5 (0.27 to 74.51) |
| Slow walking speed | 8 | 3 358 | 2.56 | (1.96–3.33) | 0.94 | 0% | Bloch et al., 2013 [ | 5.0 (2.0 to 12.0) | Not estimable |
| Walking problem | 29 | 20 309 | 2.48 | (2.24–2.75) | 0.91 | 78% | Bloch et al., 2013 [ | ||
| Unable to get up from a chair | 10 | 9 973 | 2.44 | (1.92–3.09) | 0.89 | 78% | Bloch et al., 2013 [ | ||
|
| 6 | 1 274 | 2.39 | (1.50–3.79) | 0.87 | 77% | Bloch et al., 2013 [ | ||
| Self-perceived balance problem | 4 | 3 118 | 2.36 | (1.83–3.03) | 0.86 | 28% | Bloch et al., 2013 [ | 3.5 (1.5 to 7.5) | 1.84 (0.66 to 5.17) |
|
| 9 | 3 749 | 2.35 | (1.63–3.40) | 0.85 | 77% | Bloch et al., 2013 [ | ||
|
| 16 | 7 814 | 2.26 | (1.79–2.85) | 0.82 | 78% | Bloch et al., 2013 [ | ||
|
| 9 | 1565 | 2.12 | (1.46–3.08) | 0.75 | 76% | Bloch et al., 2013 [ | ||
|
| 14 | 4 318 | 2.1 | (1.72–2.55) | 0.74 | 90% | Bloch et al., 2013 [ | ||
|
| 19 | 8 691 | 1.89 | (1.65–2.17) | 0.64 | 78% | Bloch et al., 2013 [ | ||
|
| 7 | 5 923 | 1.78 | (1.44–2.21) | 0.58 | 47% | Bloch et al., 2013 [ | ||
| Reduced mobility | 11 | 24 526 | 1.58 | (1.44–1.74) | 0.46 | 0% | Bloch et al., 2013 [ | 1.18 (0.47 to 2.97) | |
|
| 18 | 15 014 | 1.5 | (1.23–1.82) | 0.41 | 54% | Bloch et al., 2013 [ | ||
| Dizziness | 20 | 22 142 | 1.36 | (1.13–1.63) | 0.31 | 12% | Bloch et al., 2013 [ | 1.71 (0.69 to 4.24) | |
| Limited activity | 13 | 16 198 | 1.32 | (1.01–1.72) | 0.28 | 0% | Bloch et al., 2013 [ | ||
|
| 26 | 8 981 | 0.79 | (0.71–0.88) | −0.24 | 50% | Bloch et al., 2013 [ | ||
| Walking aid | 36 | 54 336 | 2.1 | (1.90–2.32) | 0.74 | 61% | Bloch et al., 2013 [ | 9.39 (1.17 to 0) | |
|
| 5 | 1 671 | 1.97 | (1.48–2.62) | 0.68 | 83% | Bloch et al., 2013 [ | ||
| Obstacle on the ground | 6 | 7 522 | 1.73 | (1.55–1.93) | 0.55 | 24% | Bloch et al., 2013 [ | 1.54 (0.48 to 5.03) | |
| Disturbance of one or more ADL | 13 | 17206 | 2.28 | (2.10–2.48) | 0.82 | 58% | Bloch et al., 2010 [ | Not estimable | |
| Frequent toileting | 1 | 533 | 1.92 | (1.12–3.27) | 0.62 | — | Sherrington et al., 2010 [ | 1.26 (0.47 to 3.34) | |
| Pain | 14 | 17926 | 1.56 | (1.36–1.79 | 0.44 | 52% | Stubbs et al., 2014 [ | 1.61 (0.63 to 4.08) | |
| Dual task | 21 | 1.33 | (1.18–1.50) | 0.29 | 89% | Chu et al., 2013 [ | Not estimable |
Empty cells indicate that the values were not reported in the meta-analyses. Italic indicates variables that were not assessed with our questionnaire.
Figure 1Study diagram.
Distribution of risk factors. Distribution of risk factors for all participants, for the nonfallers, and for the fallers. All responses are self-reported values and not observed or measured values.
| Variables | All | Non fallers during 6 months of follow-up | Fallers during 6 months of follow-up | Risk ratio (95% CI) | |||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| Age | 134 | 69.28 (5.59) | 68.65 (5.4) | 72 (5.66) | |||
| Body mass index | 134 | 25.95 (4.04) | 25.85 (4) | 26.4 (4.25) | |||
| Women | 134 | 60 (45%) | 109 | 49 (45%) | 25 | 11 (44%) | 0.97 (0.47 to 1.98) |
| Obese persons (BMI ≥ 30) | 134 | 18 (13%) | 109 | 15 (14%) | 25 | 3 (12%) | 0.88 (0.29 to 2.64) |
| BMI < 18.5 | 134 | 2 (1%) | 109 | 1 (1%) | 25 | 1 (4%) | 2.75 (0.66 to 11.52) |
| Fallen during last 12 months | 134 | 2 (1%) | 109 | 1 (1%) | 25 | 1 (4%) | 2.75 (0.66 to 11.52) |
| Emergency room visit after fall in last 12 months | 134 | 24 (18%) | 109 | 17 (16%) | 25 | 7 (28%) | 1.78 (0.84 to 3.79) |
| Fracture after fall during last 12 months | 134 | 2 (1%) | 109 | 1 (1%) | 25 | 1 (4%) | 2.75 (0.66 to 11.52) |
| Commotio after fall during last 12 months | 134 | 1 (1%) | 109 | 0 (0%) | 25 | 1 (4%) | 5.54 (3.86 to 7.96) |
| Fear of falls after fall during last 12 months | 134 | 1 (1%) | 109 | 0 (0%) | 25 | 1 (4%) | 5.54 (3.86 to 7.96) |
| Resting more than half an hour on floor after fall in last 12 months | 134 | 4 (3%) | 109 | 2 (2%) | 25 | 2 (8%) | 2.83 (0.99 to 8.06) |
| Needing help for activities of daily living | 134 | 0 (0%) | 109 | 0 (0%) | 25 | 0 (0%) | 0 (0 to 0) |
| Using walking aids | 134 | 1 (1%) | 109 | 0 (0%) | 25 | 1 (4%) | 5.54 (3.86 to 7.96) |
| Walking slower or making more breaks | 134 | 3 (2%) | 109 | 1 (1%) | 25 | 2 (8%) | 3.8 (1.57 to 9.17) |
| Problems crossing road at traffic light during green phase | 134 | 1 (1%) | 109 | 1 (1%) | 25 | 0 (0%) | 0 (0 to 0) |
| Stumbling at least once per months | 134 | 0 (0%) | 109 | 0 (0%) | 25 | 0 (0%) | 0 (0 to 0) |
| Unsecure if walking in darkness | 134 | 2 (1%) | 109 | 0 (0%) | 25 | 2 (8%) | 5.74 (3.96 to 8.32) |
| Unsecure even if walking in daylight | 134 | 3 (2%) | 109 | 1 (1%) | 25 | 2 (8%) | 3.8 (1.57 to 9.17) |
| Vision problems | 134 | 1 (1%) | 109 | 0 (0%) | 25 | 1 (4%) | 5.54 (3.86 to 7.96) |
| Seeing good without glasses | 134 | 5 (4%) | 109 | 3 (3%) | 25 | 2 (8%) | 2.24 (0.72 to 6.98) |
| Seeing good with glasses | 134 | 25 (19%) | 109 | 24 (22%) | 25 | 1 (4%) | 0.18 (0.03 to 1.28) |
| Does not see good with glasses | 134 | 106 (79%) | 109 | 84 (77%) | 25 | 22 (88%) | 1.94 (0.62 to 6.01) |
| Hearing problem | 134 | 4 (3%) | 109 | 2 (2%) | 25 | 2 (8%) | 2.83 (0.99 to 8.06) |
| Hearing problem but wearing hearing aid | 134 | 42 (31%) | 109 | 33 (30%) | 25 | 9 (36%) | 1.23 (0.59 to 2.56) |
| Taking sedative | 134 | 5 (4%) | 109 | 4 (4%) | 25 | 1 (4%) | 1.08 (0.18 to 6.44) |
| Taking blood pressure decreasing medication | 134 | 2 (1%) | 109 | 0 (0%) | 25 | 2 (8%) | 5.74 (3.96 to 8.32) |
| Taking antiepileptics | 134 | 47 (35%) | 109 | 34 (31%) | 25 | 13 (52%) | 2.01 (1 to 4.04) |
| Taking antidepressants | 134 | 2 (1%) | 109 | 2 (2%) | 25 | 0 (0%) | 0 (0 to 0) |
| Other medicaments | 134 | 3 (2%) | 109 | 1 (1%) | 25 | 2 (8%) | 3.8 (1.57 to 9.17) |
| More than one medicament | 134 | 51 (38%) | 109 | 39 (36%) | 25 | 12 (48%) | 1.5 (0.74 to 3.03) |
| Taking at least one medicament | 134 | 26 (19%) | 109 | 17 (16%) | 25 | 9 (36%) | 2.34 (1.17 to 4.68) |
| Low spirit at more than half of all days | 134 | 3 (2%) | 109 | 1 (1%) | 25 | 2 (8%) | 3.8 (1.57 to 9.17) |
| Low spirit at some days | 134 | 51 (38%) | 109 | 39 (36%) | 25 | 12 (48%) | 1.5 (0.74 to 3.03) |
| No disease | 134 | 26 (19%) | 109 | 17 (16%) | 25 | 9 (36%) | 2.34 (1.17 to 4.68) |
| Parkinson | 134 | 78 (58%) | 109 | 59 (54%) | 25 | 19 (76%) | 2.27 (0.97 to 5.33) |
| Stroke | 118 | 3 (3%) | 97 | 2 (2%) | 21 | 1 (5%) | 1.92 (0.37 to 9.97) |
| Epilepsy | 134 | 37 (28%) | 109 | 27 (25%) | 25 | 10 (40%) | 1.75 (0.86 to 3.54) |
| Diabetes | 134 | 40 (30%) | 109 | 35 (32%) | 25 | 5 (20%) | 0.59 (0.24 to 1.46) |
| Incontinence | 134 | 1 (1%) | 109 | 0 (0%) | 25 | 1 (4%) | 5.54 (3.86 to 7.96) |
| Osteoarthritis | 134 | 4 (3%) | 109 | 3 (3%) | 25 | 1 (4%) | 1.35 (0.24 to 7.68) |
| Rheumatic disease (including osteoarthritis) | 134 | 2 (1%) | 109 | 2 (2%) | 25 | 0 (0%) | 0 (0 to 0) |
| Multiple sclerosis | 134 | 4 (3%) | 109 | 3 (3%) | 25 | 1 (4%) | 1.35 (0.24 to 7.68) |
| Neurologic disease | 134 | 3 (2%) | 109 | 2 (2%) | 25 | 1 (4%) | 1.82 (0.35 to 9.39) |
| High blood pressure | 134 | 39 (29%) | 109 | 32 (29%) | 25 | 7 (28%) | 0.95 (0.43 to 2.09) |
| Fainting | 134 | 44 (33%) | 109 | 37 (34%) | 25 | 7 (28%) | 0.8 (0.36 to 1.76) |
| Leg pain during walking | 134 | 0 (0%) | 109 | 0 (0%) | 25 | 0 (0%) | 0 (0 to 0) |
| Dyspnea | 134 | 6 (5%) | 109 | 4 (4%) | 25 | 2 (8%) | 1.86 (0.56 to 6.1) |
| Heart symptoms | 134 | 28 (21%) | 109 | 20 (18%) | 25 | 8 (32%) | 1.78 (0.86 to 3.7) |
| Dizziness | 134 | 29 (22%) | 109 | 23 (21%) | 25 | 6 (24%) | 1.14 (0.5 to 2.6) |
| Wanted weight loss | 118 | 54 (46%) | 97 | 43 (44%) | 21 | 11 (52%) | 1.3 (0.6 to 2.83) |
| Unwanted weight loss | 116 | 31 (27%) | 97 | 24 (25%) | 19 | 7 (37%) | 1.6 (0.69 to 3.69) |
| Difficulties getting up from a chair | 134 | 42 (31%) | 109 | 31 (28%) | 25 | 11 (44%) | 1.72 (0.85 to 3.47) |
| Self-perceived balance problem | 134 | 36 (27%) | 109 | 27 (25%) | 25 | 9 (36%) | 1.53 (0.74 to 3.15) |
| Back pain | 134 | 36 (27%) | 109 | 27 (25%) | 25 | 9 (36%) | 1.53 (0.74 to 3.15) |
| Hip pain | 129 | 9 (7%) | 106 | 7 (7%) | 23 | 2 (9%) | 1.27 (0.35 to 4.58) |
| Knee pain | 134 | 4 (3%) | 109 | 2 (2%) | 25 | 2 (8%) | 2.83 (0.99 to 8.06) |
| Foot pain | 134 | 3 (2%) | 109 | 1 (1%) | 25 | 2 (8%) | 3.8 (1.57 to 9.17) |
| Pain yes/no | 134 | 22 (16%) | 109 | 16 (15%) | 25 | 6 (24%) | 1.61 (0.73 to 3.56) |
| Limited ROM hip | 134 | 22 (16%) | 109 | 16 (15%) | 25 | 6 (24%) | 1.61 (0.73 to 3.56) |
| Limited ROM knee | 134 | 44 (33%) | 109 | 35 (32%) | 25 | 9 (36%) | 1.15 (0.55 to 2.39) |
| Limited ROM ankle | 134 | 20 (15%) | 109 | 18 (17%) | 25 | 2 (8%) | 0.5 (0.13 to 1.94) |
| Any ROM limitation | 134 | 37 (28%) | 109 | 31 (28%) | 25 | 6 (24%) | 0.83 (0.36 to 1.91) |
| Need to get up during night | 134 | 37 (28%) | 109 | 31 (28%) | 25 | 6 (24%) | 0.83 (0.36 to 1.91) |
| Sensory deficit in lower extremity | 134 | 21 (16%) | 109 | 17 (16%) | 25 | 4 (16%) | 1.02 (0.39 to 2.68) |
| Fear of falls | 134 | 85 (63%) | 109 | 67 (62%) | 25 | 18 (72%) | 1.48 (0.67 to 3.3) |
| Low standing confidence | 134 | 16 (12%) | 109 | 12 (11%) | 25 | 4 (16%) | 1.4 (0.55 to 3.57) |
| Perceived dual task problems | 134 | 24 (18%) | 109 | 20 (18%) | 25 | 4 (16%) | 0.87 (0.33 to 2.31) |
| Cables on the floor at home | 134 | 5 (4%) | 109 | 5 (5%) | 25 | 0 (0%) | 0 (0 to 0) |
| Loose carpets at home | 134 | 39 (29%) | 109 | 31 (28%) | 25 | 8 (32%) | 1.15 (0.54 to 2.43) |
| Objects on the floor | 134 | 97 (72%) | 109 | 78 (72%) | 25 | 19 (76%) | 1.21 (0.52 to 2.79) |
| Objects on the stairs | 134 | 16 (12%) | 109 | 12 (11%) | 25 | 4 (16%) | 1.4 (0.55 to 3.57) |
| Thresholds in doors | 134 | 13 (10%) | 109 | 10 (9%) | 25 | 3 (12%) | 1.27 (0.44 to 3.67) |
| No bath mat | 134 | 22 (16%) | 109 | 16 (15%) | 25 | 6 (24%) | 1.61 (0.73 to 3.56) |
| Any home hazard | 134 | 1 (1%) | 109 | 0 (0%) | 25 | 1 (4%) | 5.54 (3.86 to 7.96) |
| Weak legs | 134 | 24 (18%) | 109 | 19 (17%) | 25 | 5 (20%) | 1.15 (0.48 to 2.75) |
Figure 2Receiver operating characteristic curve.
Figure 3Probability for fall. Calibration plot of observed versus estimated probability for fall.